誘発性深静脈血栓症後の小児の抗凝固期間を短縮する
Benjamin Feijóo1, Roxanne Radi2, Corey Lyon1
1From the University of Colorado Family Medicine Residency, Aurora, CO (BF, RR, CL).
Journal of the American Board of Family Medicine : JABFM
|August 25, 2025
まとめ
誘発性深静脈血栓症 (DVT) の若い患者では,6週間の抗凝固治療は3ヶ月の治療法と同じくらい効果的です. この発見は,小児および青少年のDVTの治療期間を短くすることを支持しています.
科学分野:
- ヘマトロジー
- 小児血栓症
- 血管医学
背景:
- 深静脈血栓症 (DVT) は重要な血管疾患である.
- 小児および青少年における最適の抗凝固期間については,現在も調査中です.
- 若者における誘発性DVTは 独特の管理上の課題をもたらします
研究 の 目的:
- 21歳未満の患者で6週間の抗凝固薬と3ヶ月の抗凝固薬の有効性と安全性を比較する.
- 抗凝固期間を短くする非劣等性を決定する.
- 小児の DVT 管理のための臨床ガイドラインを参考にします.
主な方法:
- 将来の研究デザイン
- DVTが初めて発症した21歳未満の患者を含む.
- ランダム化して6週間または3ヶ月間の抗凝固剤治療.
- 再発性静脈血栓塞栓症および出血のモニタリング
主要な成果:
- 6週間の抗凝固治療は,再発性DVTの予防に3ヶ月より劣らないことが判明しました.
- 2つの治療期間間の主要な出血事件の有意な違いはありません.
- この研究は,その主要な非劣等性エンドポイントを満たした.
結論:
- 21歳未満の患者では,誘発性DVTの治療には,3ヶ月間の治療に代わる,安全で効果的な治療である.
- 治療の負担と潜在的な合併症を減らすことができます.
- 発見は,誘発因子と患者の年齢に基づいて個別化された治療戦略を支持しています.
関連する概念動画
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40


